Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma

Functional and Integrative Genomics

Volumn 7, Issue 1, 2007, Pages 79-93

  Lee, Yuan Chii Gladys ^a   Hwang, Yu Chyi ^e   Chen, Kuang Chi ^c   Lin, Yong Shiang ^b   Huang, Dah Yeou ^e   Huang, Tao Wei ^e   Kao, Cheng Yan ^e   Wu, Han Chung ^f   Lin, Chin Tarng ^d,f   Huang, Chi Ying F ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Epstein Barr virus (EBV); Nasopharyngeal carcinoma (NPC); Quantitative real time reverse transcriptase polymerase chain reaction (Q RT PCR); Transcriptomes

Indexed keywords

ACTIN; BINDING PROTEIN; CASPASE 3; CELL ANTIGEN; DEATH ASSOCIATED PROTEIN KINASE; MIDKINE; MYC PROTEIN; MYOSIN LIGHT CHAIN; PROTEIN KINASE C; SOMATOMEDIN BINDING PROTEIN; SYNDECAN; SYNTROPHIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HOST; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; VIRUS INFECTION;

CARCINOMA; CELL LINE; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS;

HUMAN HERPESVIRUS 4;

EID: 33751547242     PISSN: 1438793X     EISSN: 14387948     Source Type: Journal    
DOI: 10.1007/s10142-006-0035-2     Document Type: Article

References (53)

1. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE (1983) Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 43:2967-2970
2. Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689-2697
3. Busson P, Ganem G, Flores P, Mugneret F, Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M, Tursz T (1988) Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42:599-606
4. Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH (1998) Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Lab Invest 78:715-726
5. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin JF, Joab I (1993) Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197:358-365
6. Depper JM, Bluestein HG, Zvaifler NJ (1981) Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 127:1899-1902
7. Epstein MA (1978) Epstein-Barr virus-discovery, properties and relationship to nasopharyngeal carcinoma. IARC Sci Publ: 333-345
8. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P et al (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338
9. Feng P, Chan SH, Ooi EE, Soo MY, Loh KS, Wang D, Ren EC, Hu H (1999) Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: Correlation with humoral immune response to lytic replication of Epstein-Barr virus. Int J Oncol 15:167-172
10. Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, Tursz T, Raab-Traub N (1991) Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo. J Virol 65:6252-6259
11. Gunven P, Klein G, Henle G, Henle W, Clifford P (1970) Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature 228:1053-1056
12. Henle W, Henle G (1970) Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma. Bibl Haematol (36):706-713
13. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE (1989) EBV gene expression in an NPC-related tumour. EMBO J 8:2639-2651
14. Ho CK, Lo WC, Huang PH, Wu MT, Christiani DC, Lin CT (1999) Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulphuric acid vapour. Occup Environ Med 56:426-428
15. Hsiao JR, Jin YT, Tsai ST (2002) Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 94:723-729
16. Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371-4378
17. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO (1985) Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann Intern Med 102:1-7
18. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T et al (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455-457
19. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS (1974) Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A 71:4737-4741
20. Leung SY, Chung LP, Yuen ST, Ho CM, Wong MP, Chan SY (1995) Lymphoepithelial carcinoma of the salivary gland: In situ detection of Epstein-Barr virus. J Clin Pathol 48:1022-1027
21. Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF (1985) Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312:1296-1299
22. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM (1990) Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62:713-724
23. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC (1993) Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68:716-727
24. Lin CT, Dee AN, Chen W, Chan WY (1994) Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines. Lab Invest 71:731-736
25. Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY (1997) The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 150:1745-1756
26. Lin CT, Kao HJ, Lin JL, Chan WY, Wu HC, Liang ST (2000) Response of nasopharyngeal carcinoma cells to Epstein-Barr virus infection in vitro. Lab Invest 80:1149-1160
27. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Tsai CS, Wei YH (2001) Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: Relationship to distant metastasis and survival. J Clin Oncol 19:2607-2615
28. Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhang J, Lee JC, Hjelm NM, Johnson PJ, Huang DP (1999) Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59:5452-5455
29. Lo YM, Chan WY, Ng EK, Chan LY, Lai PB, Tam JS, Chung SC (2001) Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma. Clin Cancer Res 7:1856-1859
30. Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5:423-428
31. Luka J, Deeb ZE, Hartmann DP, Jenson B, Pearson GR (1988) Detection of antigens associated with Epstein-Barr virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas. J Natl Cancer Inst 80:1164-1167
32. Miyasaka N, Yamaoka K, Tateishi M, Nishioka K, Yamamoto K (1989) Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjogren's syndrome. J Autoimmun 2:427-432
33. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1989) Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689-695
34. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I et al (1991) Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165:17-24
35. Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K (1999) Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression J Virol 73:1286-1292
36. Novoradovskaya N, Whitfield ML, Basehore LS, Novoradovsky A, Pesich R, Usary J, Karaca M, Wong WK, Aprelikova O, Fero M, Perou CM, Botstein D, Braman J (2004) Universal reference RNA as a standard for microarray experiments. BMC Genomics 5:20
37. Ohigashi H, Koshimizu K, Tokuda H, Hiramatsu S, Jato J, Ito Y (1985) Epstein-Barr virus-inducing activity of Euphorbiaceae plants commonly grown in Cameroon. Cancer Lett 28:135-141
38. Raab-Traub N, Hood R, Yang CS, Henry B 2nd, Pagano JS (1983) Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48:580-590
39. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227-235
40. Sbih-Lammali F, Berger F, Busson P, Ooka T (1996a) Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells. Virology 222:64-74
41. Sbih-Lammali F, Djennaoui D, Belaoui H, Bouguermouh A, Decaussin G, Ooka T (1996b) Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in North African nasopharyngeal carcinoma. J Med Virol 49:7-14
42. Sixbey JW, Yao QY (1992) Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578-1580
43. Straus SE, Dale JK, Wright R, Metcalfe DD (1988) Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 81:791-795
44. Teng ZP, Ooka T, Huang DP, Zeng Y (1996) Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes 13:53-60
45. Teramoto N, Maeda A, Kobayashi K, Hayashi K, Oka T, Takahashi K, Takada K, Klein G, Akagi T (2000) Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity. Lab Invest 80:303-312
46. Tsai ST, Jin YT, Su IJ (1996) Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer 77:231-236
47. Vasef MA, Ferlito A, Weiss LM (1997) Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol 106:348-356
48. Waterhouse L, Muir C, Shanmugaratnam K, Powell J, Peachham D, Whelan S (1982) Cancer incidence in five continents. International Agency for Research on Cancer, Lyon
49. Winrow VR, Norton J, Holborow EJ, Stierle HE, Young A, Sachs JA (1988) T cell cytotoxicity to Epstein-Barr virus infected B cells: Comparison of patients with rheumatoid arthritis and their HLA identical siblings. Ann Rheum Dis 47:280-285
50. Wu HC, Lin YJ, Lee JJ, Liu YJ, Liang ST, Peng Y, Chiu YW, Wu CW, Lin CT (2003) Functional analysis of EBV in nasopharyngeal carcinoma cells. Lab Invest 83:797-812
51. Wu HC, Lu TY, Lee JJ, Hwang JK, Lin YJ, Wang CK, Lin CT (2004) MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest 84:1547-1556
52. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69(Pt 5):1051-1065
53. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056-1058